Neuland Laboratories Limited has informed the Exchange regarding 'Compliance Certificate Pursuant To SEBI Exemption Order Dated January 3, 2025 For The Financial Year Ended March 31, 2026'.
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Davuluri Ownership Trust (a promoter-linked entity of Neuland Laboratories) has filed an annual compliance certificate with BSE, NSE, and SEBI for FY ended March 31, 2026. This filing is required under a SEBI Exemption Order dated January 3, 2025, read with Regulation 11 of the SEBI Takeover Code (SAST Regulations, 2011). The Trust was granted an exemption from certain takeover code obligations, and an independent auditor (M/s. B Srinivasa Rao & Co.) has verified and certified that the Trust has complied with all stipulated conditions during the year. The certificate was signed by auditor Ranga Rao Ch on April 7, 2026, and submitted to exchanges on April 9, 2026.
This is a routine regulatory compliance filing by a promoter-group trust and has no direct impact on the company's operations, financials, or share price. It simply confirms that the promoter entity continues to meet the conditions attached to its SEBI exemption from takeover code provisions. Shareholders need not take any action.